Literature DB >> 15563567

Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis.

Braden Manns1, Marcello Tonelli, Serdar Yilmaz, Helen Lee, Kevin Laupland, Scott Klarenbach, Val Radkevich, Brendan Murphy.   

Abstract

Despite the importance of hemodialysis vascular access, the cost of vascular access care has not been studied in detail. A prospective cost analysis was performed among incident hemodialysis patients to determine the cost of vascular access care overall and on the basis of access type. Detailed clinical and demographic information, as well as data on access type, was collected for all local incident hemodialysis patients between July 1, 1999, and November 1, 2001. A comprehensive measure of total vascular access costs, including surgery, radiology, hospitalization for access complications, physician costs, costs for management of outpatient bacteremia, and vascular access monitoring costs, was obtained. Costs are reported in 2002 Canadian dollars (1 CAN dollar = 0.69 US dollar). A total of 239 consecutive incident hemodialysis patients were identified, 49, 157, and 33 of whom were dialyzed exclusively with a catheter or had a native arteriovenous fistula or synthetic graft attempted, respectively. In year 1, 18.4% of all hospital admissions were for vascular access-related complications. The mean cost of all vascular access care in year 1 was 6890 CAN dollars(median 4020 dollars; interquartile range [IQR] 2440 dollars to 7540 dollars). The mean cost of access care per patient-year at risk for maintaining a catheter exclusively, attempting an arteriovenous fistula, or attempting a graft was 9180 dollars (median 3812 dollars; IQR 2250 dollars to 7762 dollars), 7989 dollars (median 4641 dollars ; IQR 3035 dollars to 8832 dollars), and 11,685 dollars (median 8152 dollars; IQR 3395 dollars to 12,908 dollars), respectively (P = 0.01). Vascular access care is responsible for a significant proportion of health care costs in the first year of hemodialysis. These results support clinical practice guidelines that recommend preferential placement of a native fistula.

Entities:  

Mesh:

Year:  2004        PMID: 15563567     DOI: 10.1681/ASN.2004050355

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  58 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Provider Visits and Early Vascular Access Placement in Maintenance Hemodialysis.

Authors:  Kevin F Erickson; Matthew Mell; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2014-12-01       Impact factor: 10.121

3.  Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.

Authors:  Douglas M Silverstein; Scott O Trerotola; Timothy Clark; Garth James; Wing Ng; Amy Dwyer; Marius C Florescu; Roman Shingarev; Stephen R Ash
Journal:  Clin J Am Soc Nephrol       Date:  2018-10-11       Impact factor: 8.237

Review 4.  A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy.

Authors:  Joseph Menzin; Lisa M Lines; Daniel E Weiner; Peter J Neumann; Christine Nichols; Lauren Rodriguez; Irene Agodoa; Tracy Mayne
Journal:  Pharmacoeconomics       Date:  2011-10       Impact factor: 4.981

5.  An economic evaluation of rt-PA locking solution in dialysis catheters.

Authors:  Braden J Manns; Nairne Scott-Douglas; Marcello Tonelli; Pietro Ravani; Martine LeBlanc; Marc Dorval; Rachel Holden; Louise Moist; Charmaine Lok; Deborah Zimmerman; Flora Au; Brenda R Hemmelgarn
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

6.  Risk factors associated with inadequate veins for placement of arteriovenous fistulas for hemodialysis.

Authors:  Yuichi Sato; Masahito Miyamoto; Shina Sueki; Tsutomu Sakurada; Kenjiro Kimura; Ryuto Nakazawa; Maki Yoshioka; Hideo Sasaki; Satetsu Miyano; Tatsuya Chikaraishi
Journal:  J Artif Organs       Date:  2013-09-11       Impact factor: 1.731

7.  Neuromuscular electrostimulation: a new therapeutic option to improve radio-cephalic arteriovenous fistula maturation in end-stage chronic kidney disease patients.

Authors:  Lucia Martinez; Vicent Esteve; Montserrat Yeste; Vicent Artigas; Secundino Llagostera
Journal:  Int Urol Nephrol       Date:  2017-04-21       Impact factor: 2.370

8.  Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients.

Authors:  Luis A Coentrão; Carla S Araújo; Carlos A Ribeiro; Claúdia C Dias; Manuel J Pestana
Journal:  Perit Dial Int       Date:  2013-03-01       Impact factor: 1.756

9.  Variation in fistula use across dialysis facilities: is it explained by case-mix?

Authors:  Navdeep Tangri; Ranjani Moorthi; Hocine Tighiouhart; Klemens B Meyer; Dana C Miskulin
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

10.  Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Authors:  Ashley Irish; Gursharan Dogra; Trevor Mori; Elaine Beller; Stephane Heritier; Carmel Hawley; Peter Kerr; Amanda Robertson; Johan Rosman; Peta-Anne Paul-Brent; Melissa Starfield; Kevan Polkinghorne; Alan Cass
Journal:  BMC Nephrol       Date:  2009-01-21       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.